Okla. Stat. tit. 63, § 63-1-756.8

– Annual statistical report upon data gathered.

A. For the purpose of promoting maternal health and adding to

the sum of medical and public health knowledge through the

compilation of relevant data, a report of each drug-induced abortion

performed shall be made to the State Department of Health on forms

prescribed by it. The reports shall be completed by the hospital or

other licensed facility in which the abortion-inducing drug was

given, sold, dispensed, administered or otherwise provided or

prescribed; signed by the qualified physician who gave, sold,

dispensed, administered or otherwise provided or prescribed the

abortion-inducing drug; and transmitted to the Department within

fifteen (15) days after each reporting month.

B. Each report shall include, at minimum, the following

information:

1. Identification of the qualified physician who provided the

abortion-inducing drug;

2. Whether the chemical abortion was completed at the hospital

or licensed facility in which the abortion-inducing drug was

provided or at an alternative location;

3. The referring physician, agency or service, if any;

4. The pregnant woman's age and race;

5. The number of previous pregnancies, number of live births

and number of previous abortions of the pregnant woman;

6. The probable gestational age of the unborn child as

determined by both patient history and by ultrasound results used to

confirm the gestational age. The report shall include the date of

the ultrasound and gestational age determined on that date;

7. The abortion-inducing drug or drugs used, the date each was

provided to the pregnant woman and the reason for the abortion, if

known;

8. Preexisting medical conditions of the pregnant woman which

would complicate her pregnancy, if any;

9. Whether the woman returned for a follow-up examination to

determine completion of the abortion procedure and to assess

Oklahoma Statutes - Title 63. Public Health and Safety Page 449

bleeding and the date and results of any such follow-up examination,

and what reasonable efforts were made by the qualified physician to

encourage that she return for a follow-up examination if she did

not;

10. Whether the woman suffered any complications, and what

specific complications arose and any follow-up treatment needed; and

11. The amount billed to cover the treatment for specific

complications including whether the treatment was billed to

Medicaid, private insurance, private pay or other method. This

shall include charges for any physician, hospital, emergency room,

prescription or other drugs, laboratory tests and any other costs

for treatment rendered.

C. Reports required under this subsection shall not contain:

1. The name of the pregnant woman;

2. Common identifiers such as her social security number or

driver license number; or

3. Other information or identifiers that would make it possible

to identify, in any manner or under any circumstances, a woman who

has obtained or seeks to obtain a chemical abortion.

D. If a qualified physician provides an abortion-inducing drug

to a pregnant woman for the purpose of inducing an abortion as

authorized in Sections 2 and 3 of this act, and if the qualified

physician knows that the woman who uses the abortion-inducing drug

for the purpose of inducing an abortion experiences, during or after

the use of the abortion-inducing drug, an adverse event, the

qualified physician shall provide a written report of the adverse

event within three (3) days of the event to the Food and Drug

Administration via the Medwatch Reporting System, and to the

Department and to the State Board of Medical Licensure and

Supervision.

E. Any physician, qualified physician, associated physician or

other healthcare provider who treats a woman, either

contemporaneously to or at any time after the procedure, for an

adverse event or complication related to a chemical abortion shall
Food and Drug

Administration via the Medwatch Reporting System, and to the

Department and to the State Board of Medical Licensure and

Supervision.

E. Any physician, qualified physician, associated physician or

other healthcare provider who treats a woman, either

contemporaneously to or at any time after the procedure, for an

adverse event or complication related to a chemical abortion shall

make a report of the adverse event to the Department on forms

prescribed by it. The reports shall be completed by the hospital or

other facility in which the adverse event treatment was provided;

signed by the physician, qualified physician or other healthcare

provider who treated the adverse event; and transmitted to the

Department within (15) days after each reporting month.

F. The Department shall prepare a comprehensive annual

statistical report for the Legislature based upon the data gathered

from reports under this section. The aggregated data shall also be

made available to the public by the Department in a downloadable

format.

Oklahoma Statutes - Title 63. Public Health and Safety Page 450

G. The Department shall summarize aggregate data from the

reports required under this act and submit the data to the Centers

for Disease Control and Prevention.

H. Reports filed pursuant to this section shall be public

records and shall be available to the public in accordance with the

confidentiality and public records reporting laws of this state.

Copies of all reports filed under this subsection shall be available

to the State Board of Medical Licensure and Supervision, State Board

of Pharmacy, state law enforcement offices and child protective

services for use in the performance of their official duties.

I. Absent a valid court order or judicial subpoena, neither the

Department, any other state department, agency or office nor any

employees thereof shall compare data concerning abortions or

abortion complications maintained in an electronic or other

information system file with data in any other electronic or other

information system with the intention of identifying, in any manner

or under any circumstances, a woman obtaining or seeking to obtain a

drug-induced abortion.

J. Statistical information that may reveal the identity of a

woman obtaining or seeking to obtain a drug-induced abortion shall

not be publicly disclosed by the Department, any other state

department, agency, office or any employee or contractor thereof.

K. Copies of all reports filed under this section shall be

available to the Department and the State Board of Medical Licensure

and Supervision for use in the performance of its official duties.

L. The Department shall communicate the reporting requirements

in this section to all medical professional organizations, licensed

physicians, hospitals, emergency rooms, abortion facilities,

clinics, ambulatory surgical facilities and other healthcare

facilities operating in this state.

M. Any physician including emergency medical personnel, who

treats a woman for complications or adverse event arising from an

abortion, shall file a written report as required by this section of

this act with the Department.

N. A physician filing a written report with the Department

after treating a woman for complications or otherwise in an

emergency capacity shall make reasonable efforts to include all of

the required information that may be obtained without violating the

privacy of the woman.